Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06454266
Status:
COMPLETED
Last Update Posted:
2024-06-12
First Post:
2024-05-05
Brief Title:
First-line Treatment of PCNSL With the Combination of Orelabrutinib Rituximab and Methotrexate ORM Regimen
Sponsor:
Ningbo No 1 Hospital
Organization:
Ningbo No 1 Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Central Nervous System Lymphoma |
Keywords: